Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Oct 13, 2026

CSBR — Champions Oncology, Inc. Dilution Risk Tracker

Track CSBR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CSBR — Get alerts when the score changes →

As of October 13, 2026, Champions Oncology, Inc. (CSBR) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Champions Oncology, Inc. has a market capitalization of $67.37M, 13.92M shares outstanding, 26 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
62
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CSBR.
🔔 Track CSBR — Get forecast alerts →

Market Data

Market Cap$67.37M
Shares Outstanding13.92M
Float5.19M
Cash$4.36M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore43/100DilutionWatch score record
Shares Outstanding13.92MVerified float table or market cache
Public Float5.19MVerified float table or market cache
Market Cap$67.37MMarket data cache
Cash Runway14.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 3 1, 4 2, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 11.5% shares (2026Q1 vs prior)
26 institutional holders · 6.47M shares
#1 BATTERY MANAGEMENT CORP. 2.42M shares
#2 NEA Management Company, LLC 1.71M shares
#3 MORGAN STANLEY 661.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest71.0K
Days to Cover4.4
% of Float1.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2016-07-29
4 INSIDER TRANSACTION 2026-01-30
4 INSIDER TRANSACTION 2026-01-30
3 FORM3 2026-01-16
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CSBR Dilution Snapshot

Champions Oncology, Inc. (CSBR) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CSBR's DilutionScore is currently 43/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 34/100 (Medium risk).

Period Score Risk Level Duration
Sep 17 – Oct 13, 202643/100MEDIUM27 days
Jul 16 – Sep 16, 202634/100MEDIUM62 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track CSBR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CSBR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CSBR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CSBR
CSBR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.